Clinical Effect of Driver Mutations of <i>KRAS, CDKN2A/P16, TP53</i>, and <i>SMAD4</i> in Pancreatic Cancer: A Meta-Analysis

scientific article published on 01 December 2020

Clinical Effect of Driver Mutations of <i>KRAS, CDKN2A/P16, TP53</i>, and <i>SMAD4</i> in Pancreatic Cancer: A Meta-Analysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/GTMB.2020.0078
P698PubMed publication ID33347393

P2093author name stringHui Jiang
Yayun Ji
Yujun Gu
Ganbin Qiu
P2860cites workCore signaling pathways in human pancreatic cancers revealed by global genomic analysesQ24606006
P433issue12
P921main subjectpancreatic cancerQ212961
P304page(s)777-788
P577publication date2020-12-01
P1433published inGenetic Testing and Molecular BiomarkersQ15753742
P1476titleClinical Effect of Driver Mutations of <i>KRAS, CDKN2A/P16, TP53</i>, and <i>SMAD4</i> in Pancreatic Cancer: A Meta-Analysis
P478volume24

Search more.